The Latin America mycoplasma testing market was worth USD 65.12 Million in 2016 and is estimated to be growing at a CAGR of 12.3%, to reach USD 116.3 Million by 2021. The species of Mycoplasma are the smallest living organisms and are peculiar among prokaryotes due to the absence of cell wall.
- Advertising -
It is also the reason that they are not detected anti-microbial agents and for the absence of reaction to Gram stain.
Browse Full Report at www.marketdataforecast.com/market-…ting-market-3667/
They only have the minimum required components or organelles for them to replicate.
- Advertising -
Mycoplasma are largely responsible for the contamination of cell cultures in laboratories. The source of infection can be untested infected cells and contaminated individuals who enter the laboratory.
Testing for the presence of newly brought cell lines is essential before conducting experiments. There are variety of testing equipment and methods available in the market.
With the lot of research being conducted on life sciences all over the world, the demand for mycoplasma testing is increasing and is expected to grow in the forecast period. Increasing funding for research activities in cell culture and increased expenditure on healthcare by government are also expected to drive the mycoplasma testing market.
Sky-high costs associated with the mycoplasma testing and stringent government guidelines are hindering the market growth in this region.
- Kits & Reagent
- o PCR Assays
- o Nucleic Acid Detection Kits
- o Elimination Kits & Reagents
- o Stains
- o Standards & Controls
- o Other Kits & Reagents
- Y-o-Y Growth Analysis, By Product
- Market Attractiveness Analysis, By Product
- Market Share Analysis, By Product
- Direct Assays
- Indirect Assays
- Microbial culture techniques
- Enzymatic Methods
- DNA Staining
- Y-o-Y Growth Analysis, By Technique
- Market Attractiveness Analysis, By Technique
- Market Share Analysis, By Technique
- Cell Line Testing
- Virus Testing
- End-Of-Production Cell Testing
- Other Applications
- Y-o-Y Growth Analysis, By Application
- Market Attractiveness Analysis, By Application
- Market Share Analysis, By Application
- Pharmaceutical Companies
- Contract Research Organizations
- Academic Research Institutes
- Cell Banks
- Y-o-Y Growth Analysis, By End User
- Market Attractiveness Analysis, By End User
- Market Share Analysis, By End User
The mycoplasma testing market of Latin America is geographically segmented into Brazil, Argentina, Mexico and rest of South America. Due to increase in research activities on cell culture and government initiatives in funding the research on drug development are the driving the market growth in this region.
The key players in the mycoplasma testing market include Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: